Skip to main content
Premium Trial:

Request an Annual Quote

Genisphere, LIMR Expand Ulcerative Colitis miRNA Biomarker Collaboration

Premium

Genisphere and the Lankenau Institute for Medial Research said this week that they are expanding their collaboration on the development of microRNA biomarkers for ulcerative colitis to include Crohn's disease and other inflammatory bowel disorders.

In a statement, LIMR President and CEO George Prendergast said that it is “very difficult” to diagnose the subgroups of inflammatory bowel disease.

"Symptoms can be common and it's difficult to diagnose the condition precisely,” he added. “Therefore, we see an opportunity through this collaboration to provide clinicians with a tool that helps them rapidly and specifically identify the patient's condition so that care can be targeted the best."

"We want to identify biomarker panels that can classify the various forms of IBD," Genisphere CSO Bob Getts said. "From this we can develop a tool that will help to rapidly and accurately identify the patient's condition so personalized treatment may be administered as soon as possible. Better therapeutics and monitoring will lead to earlier and more successful intervention."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.